Neuroscience
Online
|
Section I:
Cellular and Molecular Neurobiology
13. Amino Acid Neurotransmitters
Part 2 of 5
Neal Waxham, Ph.D.
|
 |
Biosynthesis of Amino Acid Neurotransmitters
Amino acid neurotransmitters are all products of intermediary
metabolism with the exception of GABA. Unlike all the other amino acid neurotransmitters,
GABA is not used in protein synthesis and is produced by an enzyme (glutamic acid decarboxylase; GAD) uniquely located in neurons. Antibodies to GAD can be used to identify neurons that release GABA.
Glutamate and Aspartate
Glutamate and aspartate are products of the Kreb's cycle, and both have excitatory
effects in the CNS. They are produced in the mitochondria, transported into
the cytoplasm, and packaged into synaptic vesicles (Figure 13.4). Specific high-affinity
enzymes are responsible for packaging glutamate into vesicles.
|
Figure 13.4
|
The actions of glutamate are terminated
by high-affinity uptake systems in neurons and glia (represented by red
cylinders in the neuron and glia membranes). Under normal circumstances
most uptake is back into the neuron and this
glutamate can immediately be pumped into vesicles for subsequent release.
When neuronal activity is high, extracellular glutamate concentration exceeds
the capacity of neuronal uptake. At this point, uptake systems in glial
cells help absorb the excess glutamate. However, glutamate is not permeable
to the plasma membrane. To recycle the glutamate taken up into glial cells,
an enzymatic reaction catalyzed by glutamine synthase
produces glutamine from glutamate (Figure 13.4). Glutamine is freely permeable
to the glial and neuronal plasma membranes and diffuses back into the neuron.
The neuronal enzyme glutaminase then metabolizes
glutamine into glutamate where it can then be packaged into synaptic vesicles
for another round of release (Figure 13.4). |
Glycine
| Glycine is the main neurotransmitter
that mediates the inhibitory actions of spinal cord interneurons. It is
also present in lower amounts throughout the nervous system. Glycine is
synthesized from serine in the mitochondria (Figure 13.5). The reaction
is catalyzed by the enzyme serine transhydroxymethylase
(Figure 13.5; click on box). Like glutamate, high-affinity uptake systems
remove glycine from the synaptic cleft, which can then be repackaged into
vesicles.
The binding of glycine to its receptor on postsynaptic neurons is blocked
by the poison strychnine,
thus blocking glycine's inhibitory actions (Figure 13.5). The block of
inhibition leads to hyperexcitation and typically a patient with strychnine
poisoning asphyxiates due to an inability to relax the diaphragm. More
details on the nature of glycine receptors are provided later in this
chapter. (You can move forward to it
now, but be aware that you are advancing FORWARD.)
|
Figure 13.5 |
GABA
Figure 13.6
|
GABA mediates the majority of inhibitory
synaptic actions in the CNS. GABA is synthesized from glutamate in a reaction
catalyzed by glutamic acid decarboxylase (GAD;
Figure 13.6). Antibodies to GAD can be used to identify GABAergic neurons.
Like the other amino acid transmitters, GABA's actions are terminated by
high affinity uptake systems in neurons and glia. Neuronal uptake permits
immediate repackaging into vesicles for release. Compared with glutamate,
a more elaborate set of reactions is necessary to return GABA to the neuron
when it is taken up by glial cells. Some of these enzymes are shared with
those for returning released glutamate to neurons described in Figure 13.4.
GABA is first converted back into glutamate by the mitochondrial enzyme
GABA transaminase (GABA-T; Figure 13.6; click on box) using the -COOH group
from alpha-ketoglutarate. This pathway is sometimes referred to as the "GABA
shunt". The glutamate is then converted to glutamine by the enzyme glutamine
synthase and glutamine diffuses back into the neuron. Finally, glutaminase
converts glutamine into glutamate, which can again serve as a substrate
for GAD, completing the cycle. |
Ca2+-Dependent Release
All of these amino acid neurotransmitters are released by
Ca2+-dependent exocytosis
at presynaptic specializations as discussed in Chapter 8,
Part 7 and Chapter 10, Part 4. All vesicles (both
small molecule and neuropeptide) also contain ATP that is co-released when these
vesicles fuse with the membrane. ATP and its degradation product adenosine are
themselves neurotransmitter molecules (termed purinergic transmission) that
can also modify the pre- or postsynaptic cell's response if the appropriate
receptors are present. For example, adenosine is a potent inhibitor of neurotransmitter
release from presynaptic terminals.
Test Your Knowledge
|
| 14. Glutamate up-take into glial cells: |
A. Is a dead-end pathway.
B. Is by passive diffusion.
C. Results in its metabolism into glutamine
by glutaminase.
D. Results in its metabolism into glutamine
by glutamine synthase.
E. Results in its metabolism into GABA by
glutamic acid decarboxylase.
|
Contact the author(s) at: nba_course@uth.tmc.edu
Copyright © 1997-present, All Rights Reserved
The University of Texas Health Science Center at Houston
Created through the Multimedial Scriptorium - Academic Technology